Myrum Stanton Dean 4
4 · ProUroCare Medical Inc. · Filed May 10, 2013
Insider Transaction Report
Form 4
Myrum Stanton Dean
DirectorCEO
Transactions
- Award
Warrants
2013-05-08+77,600→ 77,600 totalExercise: $0.50Exp: 2018-05-08→ Common stock, $0.00001 par value (77,600 underlying) - Award
Warrants
2013-05-08+150,000→ 227,600 totalExercise: $0.50Exp: 2018-05-08→ Common stock, $0.00001 par value (150,000 underlying)
Holdings
- 21,000
Common Stock, $0.00001 par value
Footnotes (3)
- [F1]The reporting person agreed to accept 77,600 warrants in lieu of cash for $19,400 of unpaid consulting fees. The Issuer's Board of Directors specifically approved the issueance of the warrants to the reporting person as exempt from the requirements of Section 16b as provided by Rules 16b-3(d) and 16b-3(e).
- [F2]The warrants will vest and become exercisable upon the first to occur of (a)first commercialization of the Issuer's products or (b)a change of control of the Issuer.
- [F3]The reporting person was issued the warrants as a commitment fee pursuant to a consulting agreement. The Issuer's Board of Directors specifically approved the issueance of the warrants to the reporting person as exempt from the requirements of Section 16b as provided by Rules 16b-3(d) and 16b-3(e).